turnaround drags, China sales slump

Nike Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, Dec. 31, 2025. Michael Nagle | Bloomberg | Getty Images When Nike reported fiscal third quarter earnings on Tuesday night, investors were looking for evidence its recovery is on track. Instead, all they learned is the…

Read More

Eli Lilly GLP-1 pill Foundayo approved for obesity

The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications. Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at pharmacies and on…

Read More